SUMMARY. Rhesus D (RhD) typing is performed by agglutination methods; however, in clinical situations where these techniques cannot be performed, RhD DNA typing is an alternative approach. The Rh antigens are encoded by the RHD and RHCE genes. In RhD-negative individuals the RHD gene is absent or grossly deleted, but variations in the arrangement of the RH locus in different populations are emerging. The aim of this study was to analyse the gross organization of the RH genes in our population using a previously described multiplex polymerase chain reaction (PCR) method with some modi®cations. We studied 253 DNA samples from Argentinian blood donors, 15 samples with a reduced expression of the D antigen and 1 Dc-phenotype. We evaluated the clinical utility of this method to ascertain the RhD antigen in 10 patients with warm-type autoimmune haemolytic anaemia (AIHA) and 14 samples of amniotic¯uids. All Rh phenotypes were properly characterized and no discrepancies with serological typing were found. Analyses performed in the Dc-phenotype suggest the presence of a hybrid RHCE± RHD gene. DNA typing con®rmed the RhD-negative type of one AIHA sample in which serological tests were inconclusive. Foetal DNA typing correctly indicated the RhD in every foetus. VNTR (variable number of tandem repeats) and STR (short tandem repeats) analysis detected maternal contamination in two amniocentesis samples and con®rmed the foetal origin of 12. This multiplex PCR strategy is suitable for RhD determination in clinical situations in which serological typing cannot be accomplished with its usual ease.
INTRODUCTION
The Rhesus blood group system is of clinical interest because it is involved in the pathogenesis of haemolytic disease of the newborn, haemolytic transfusion reactions, and some autoimmune haemolytic anaemias. There are ®ve most frequently typed Rh antigens: C/c, E/e and the D antigen, which is the most immunogenic, de®ning an individual as RhD positive or RhD negative. 1 Routinely, Rh typing is performed by agglutination with polyclonal and monoclonal antibodies. However, there are some clinical situations in which serological techniques cannot determine the red blood cell (RBC) phenotype accurately. In patients with autoimmune haemolytic anaemia the autoantibodies coating the RBCs can make serological typing impossible. Agglutination methods are also of limited use for determining the RBC phenotype of a foetus at risk of haemolytic disease of the newborn, as periumbilical blood sampling must be performed to obtain foetal erythrocytes. Problems may also arise when typing qualitative (partial D) and/or quantitative (weak D, formerly D U ) variants that are not agglutinated by most anti-D serum samples. When agglutination techniques become inapplicable or inconclusive, an alternative approach is to infer the RBC phenotype identifying the alleles in genomic DNA encoding the Rh antigen.
Two proteins encoded by two genes, denoted RHD and RHCE, carry the antigens of the Rh blood group system. The RHD gene encodes the D antigen, and the RHCE gene encodes the Cc and Ee antigens. Each gene consists of 10 exons with 92% sequence homology between them. 3, 4 The molecular basis for RhD-positive and RhDnegative blood type is the presence or absence of the RHD gene, rather than the hypothetical d allele. That is, RhD-positive individuals have either one or two RHD genes per cell whereas the RhD-negative phenotype is caused by the absence of the entire RHD gene or at least part of it. 5 Besides the most common RHD DNA sequence, several allelic RHD variants have been described. These result in serologically de®nable D categories (partial D) in which RhD proteins lack epitopes de®ned by monoclonal anti-D. 6, 7 Several partial D antigens permit clinically important anti-D immunization, and so their discrimination from the prevalent RHD allele in transfusion recipients would be useful to guide RhD-negative transfusion therapy. 8 Molecular studies of quantitative D variants have also been described. Some authors suggest they may occur as a consequence of a transcriptional or posttranscriptional regulation of the RHD gene expression. 9 Others found that many of these alleles encode aberrant RhD proteins with amino acid substitutions in transmembranous and intracellular RhD protein segments. 10 In some of these cases with reduced antigen density, DNA-based analyses may be better than serological typing to predict the appropriate phenotype.
Different polymerase chain reaction (PCR) ampli®cation protocols have been applied to determine the RhD type in DNA obtained from normal donor peripheral blood, amniocytes and trophoblastic cells. 11, 12 However, discrepancies between serological and PCR results have been reported. 13±15 Some authors found the presence of signi®cant portions of the RHD gene in RhDnegative individuals from Caucasian and nonCaucasian populations. 16, 17 The presence of these alleles confounds DNA typing because they may lead to false positive results. 18 In this study we analyse the gross RH gene organization in our population in all commonly occurring Rh phenotypes. We used a previously described multiplex PCR method 14, 15 with some modi®ca-tions to determine the RhD blood type in DNA samples derived from white Argentinian blood donors. RHD typing of phenotypes with reduced expression of the D antigen and a Dc sample was also performed. We evaluated the potential clinical utility of this method to ascertain the RhD antigen in patients with warm-type autoimmune haemolytic anaemia and in foetuses at risk of haemolytic disease of the newborn. The foetal origin of the DNA obtained from amniotic¯uid was con®rmed by the analysis of variable number of tandem repeats (VNTR) and short tandem repeats (STR). 19, 20 
MATERIAL AND METHODS
We studied 253 samples from white Argentinian blood donors with known Rh phenotypes, 15 blood donors with reduced expression of the D antigen detected only by the antiglobulin test, one Dc-sample, 10 patients with warm-type autoimmune haemolytic anaemia, and 14 samples of amniotic¯uids. All procedures using human samples were performed in accordance with the ethical standards established by the University of Rosario.
Serology
Routine erythrocyte blood group antigen typing was performed by standard agglutination methods using polyclonal as well as monoclonal antibodies (Ortho Diagnostic Systems, Raritan, NJ, and Gamma Biologicals, Houston, TX), as previously described.
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DNA preparation
Genomic DNA was isolated from whole peripheral blood anticoagulated with EDTA and from amniotic¯uid (without previous culturing) using a salting-out method. 21 Amniocentesis was performed for foetal lung maturity testing and for the management of alloimmunization in RhD-negative mothers. Residual amniotic¯uid was used for the current study.
PCR strategy
The multiplex PCR contains four primers. One set of primers, previously described by Simsek et al. 12 : Rh607 for a sequence located in exon 4 (5 ACGATACCCAGTTTGTCT 3 , sense primer, position 607±624) and Rh768 for a sequence located in exon 5 (5 TGACCCTGA GATGGCTGT 3 , antisense primer, position 768±751), ampli®es intron 4 of both RHCE and RHD genes. The PCR product obtained from the RHCE gene (1238 bp) is distinguished from that obtained from the RHD gene because in the latter there is a deletion in intron 4 that results in a smaller PCR product (587 bp). We designed the other set of primers based on published RHCE and RHD sequence data 3, 4 to analyse exon 10 of the RHD gene; 11, 15 Rh1228 for a sequence located in exon 10 of both RH genes (5 TTTCCTCATTTGGCTGTTG 3 , sense primer, position 1228±1246); and Rh1478 for a sequence located in the 3 non-coding region of the RHD gene (5 CATGGCTGTATTTTATTGTTGTAT 3 , antisense primer, position 1478±1455). This pair of primers yields a PCR product of 250 bp only from the RHD gene. In all cases nucleotide position 1 is considered as the ®rst residue of the initiator AUG codon of the RhCE and RhD messenger RNAs. With these four primers, a PCR product of 1238 bp is derived from the RHCE gene in all donors regardless of the Rh phenotype, whereas two PCR products of 587 bp and 250 bp derived from the RHD gene are missing when the donor is RhD negative (Fig. 1) . The presence of the 1238 bp PCR product in all samples is used as an internal control to check the ef®ciency of the enzymatic reaction. The PCR products were separated by electrophoresis on a 2% agarose gel containing 0.5 mg/L of ethidium bromide and were visualized under ultraviolet light.
PCR ampli®cation
The PCR was performed in a thermal cycler (MiniCycler, MJ Research, Watertown MA) with approximately 1 mg of genomic DNA in a ®nal volume of 25 mL containing 0´4 mmol/L of each of the four primers, 0´2 mmol/L dNTPs, 2 mmol/L MgCl 2 and one unit of Taq DNA polymerase in appropriate buffer (Promega, Madison WI). PCR conditions were: 94 C for 5 min, followed by 29 cycles of 94 C for 1 min, 58 C for 1 min, 72 C for 1´5 min, and a ®nal extension at 72 C for 7 min.
Genetic pro®le of the DNA obtained from amniotic¯uid The alleles for the apoB locus (VNTR) were determined by PCR for DNA derived from maternal and amniotic¯uid cells. PCR was performed with approximately 0´5 mg of genomic DNA. 22 The products were separated in a 6% denaturing polyacrylamide gel, 23 followed by silver staining. 24 The apoB locus consists of repetitive sequence elements of 30 bp in length and the alleles were estimated in relation to a 100 bp ladder ranging from 100 to 1500 bp. The analysis of the CSF1PO, TPOX and TH01 loci (STR) was performed by PCR (Gene Print STR Systems, Promega) on approximately 0´5 mg of maternal and amniotic¯uid genomic DNA. The ampli®ed products were separated in a 6% denaturing polyacrylamide gel, 23 followed by silver staining. 24 These STR loci consist of short, repetitive sequence elements of 4 bp in length, and their alleles were assigned in relation to commercially available allelic ladders for each locus.
Restriction enzyme analysis
Ampli®ed DNA fragments of 1238 bp and 587 bp were puri®ed from agarose gel and
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digested with restriction enzyme Taq 1 (Promega) for 4 h at 65 C. 23 Aliquots of the digests were visualized after electrophoresis on a 3% agarose gel stained with ethidium bromide.
Allele-speci®c PCR for hybrid gene
The RH locus of the Dc-sample was further analysed by a PCR that uses a forward primer speci®c for intron 4 of the RHCE gene (5 AGACTGCTGGGAGAGGCTAAT 3 ) and a reverse primer speci®c for the exon 5 of the RHD gene (5 CACCACGCTGACTGCTAC 3 ). We designed this set of primers based on published RHD and RHCE sequence data 3, 4 to amplify an 807 bp region in the presence of a hybrid gene. To check the ef®ciency of the enzymatic reaction, primers 2DRBAmpA (5 CCCCACAG CACGTTTCT(C)TG 3 , degenerate primer) and 2DRBAmpB (5 CCGCTGCACTGTGAAGCT CTA 3 ) were used in each PCR. These primers are complementary to consensus sequences of the exon 2 of the human lymphocyte antigen (HLA) class II DRB1 gene and yield a 270 bp product in all samples. Ampli®cation was carried out in a ®nal volume of 50 mL containing 0´4 mmol/L of each of the detection primers, 0´2 mmol/L dNTPs, 2 mmol/L MgCl 2 and one unit of Taq DNA polymerase (Promega) in appropriate buffer. The concentration of each control primer was 0´04 mmol/L. The cycle parameters were: 5 min at 94 C; 30 cycles of 1 min at 94 C, 1 min at 60 C and 1 min at 72 C; and 10 min at 72 C.
All samples were analysed in a double-blind fashion without knowledge of the serological results.
RESULTS
In all 253 blood donors three bands of 1238 bp, 587 bp and 250 bp were obtained from RhDpositive samples (n=168) and only one band of 1238 bp was obtained from RhD-negative individuals (n=85), as shown in Fig. 2 . In all individuals studied so far, no discrepancies between RhD phenotyping and RHD DNA typing were observed. Among RhD-negative individuals, 20 were phenotyped as dCcee, 29 as dccEe and two as dCCee. Samples with these same phenotypes were reported to give false positive results when DNA analysis was performed. 13±15 In our study, the DNA typing of all these samples agreed with their RhD-negative phenotype. In all RhD-positive samples studied so far, no false negative results were encountered.
Screening antiglobulin test, showed the presence of all RHD-speci®c PCR products (Fig. 2) .
The genotyping of a Dc-sample with no expression of E and e antigens yielded the three PCR products: 1238 bp, 587 bp and 250 bp (Fig.  2) .
This product is cut into fragments of 393 bp, 122 bp and 72 bp. The 1238 bp product from the Dc-sample was cut into four fragments of 613 bp, 431 bp, 122 bp and 72 bp (Fig. 3) . No differences were found in the restriction patterns obtained from the 1238 bp fragments of RhDpositive and -negative individuals and from the 587 bp products from the Dc-sample and RhDpositive samples. With speci®c primers for intron 4 of the RHCE gene and exon 5 of the RHD gene, an 807 bp product was obtained only from the Dc-sample. No hybrid-speci®c ampli®cation was achieved in three RhDpositive and three RhD-negative unrelated individuals studied as negative controls. In all PCR performed, the 270 bp positive ampli®ca-tion control was observed (Fig. 4) . These results account for the presence of a hybrid RHCE± RHD gene next to a normal RHD gene.
Among the 10 patients with warm-type autoimmune haemolytic anaemia, nine were genotyped as RhD positive and one as RhD negative. These results agreed with those obtained from serological tests performed after elution of the autoantibody from red blood cells in all RhD-positive patients. The DNA analysis con®rmed the RhD-negative type of one sample in which a complete dissociation of the autoantibody without damaging the RBC membrane was impossible, and did not allow us to discard a probable weak D phenotype by means of serological tests.
RHD typing of DNA from amniotic cells was compared to serological analysis of cord blood samples obtained after delivery, and correctly indicated the RhD type in every foetus. Of ®ve foetuses with RhD-negative mothers, three were identi®ed as RhD positive and two as RhD negative. Three mothers were sensitized with anti-D alloantibodies. Two of them gave birth to
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Ann Clin Biochem 2000: 37 RhD-positive babies and one to a RhD-negative baby. All of the seven foetuses with RhD-positive mothers were genotyped as RhD positive. VNTR and STR analysis failed to detect contaminating maternal sequences in 12 samples of amniotic¯uid. One of the two alleles present in the DNA obtained from amniocytes was absent in the maternal samples, con®rming that the DNA derived from amniotic¯uids was foetal in origin (Fig. 5) . Maternal contamination was found in two samples of amniotic¯uid, as determined by the presence of the two maternal alleles in addition to the paternal allele (Fig. 5) . These contaminated fetal samples were not further analysed. The analysis of four loci made it possible to solve situations in which foetus and mother have identical bands in a given locus, due not to contamination but rather to the presence in both samples of high-frequency alleles.
FIGURE 3. PCR±RFLP (restriction fragment length polymorphism) of intron 4 and exon 5 of the RH genes. This ®gure shows the polymorphism of the 1238 bp and 587 bp fragments of an RhD-positive sample and a Dc-sample analysed by digestion with Taq I. The 1238 bp fragment of the RHCE gene from RhD-positive individuals have two target sites in intron 4 yielding three fragments of 613 bp, 431 bp and 194 bp (lane 2). The 587 bp fragment of the RHD gene from RhD-positive individuals has two restriction sites, one of which is in position 695 of exon 5. This product is cut into fragments of 393 bp, 122 bp and 72 bp (lane 6). The 1238 bp product from the
DISCUSSION
In the present study we investigated the gross RH gene organization in our population by means of a multiplex PCR method. We made use of the fact that the RHCE gene has a larger intron 4 than the RHD gene, and of the presence of an RHD-speci®c sequence in the 3 untranslated region. The analysis of these two suf®-ciently distant regions of the RH locus has proved safe for the determination of the RhD phenotype. The practical application of DNA typing requires an exhaustive analysis of the polymorphism, population frequency and distribution of the alleles of the gene under study. Otherwise, DNA typing in random samples may lead to mistakes. We studied 268 DNA samples of blood donors from Argentina. All common Rh phenotypes were properly characterized and no discrepancies between serological and DNA typing were found. We tested 20 dCcee, 29 dccEe and two dCCee samples. Samples with these phenotypes have been reported to give false positive results in at least one of the DNA regions analysed. 13±15 In our study complete agreement was observed, suggesting the possibility of different genetic backgrounds among individuals with the same phenotype. Most important of all, in all DNA samples analysed so far no false negative results were found, making this multiplex PCR strategy suitable for prenatal RhD determination in our population. It is well known that some phenotypes classi®ed as weak D are in fact qualitative D variants, category D VI being the most frequently observed. On a molecular basis D VI phenotypes are characterized by hybrid RHD±CE±D gene structures resulting from segmental DNA exchange between exons 4±6, 4±5 or 3±6 of the RHD and RHCE genes. 6,8,25±27 These rearrangements lack intron 4 of the RHD gene. In this study we analysed 15 samples with reduced D antigen expression detected only by the antiglobulin test. Our DNA analysis results showed the presence of intron 4 of the RHD gene (587 bp) in all the samples, suggesting the absence of hybrid genes that cause the most clinically important D VI types. More research should be performed to differentiate qualitative and quantitative D variants by means of a practical DNA typing method. This multiplex PCR strategy is suitable to discard RhD-negative phenotypes in those samples with weak agglutination reactions.
We performed the multiplex PCR assay on a sample with no expression of E and e antigens (Dc-phenotype) and found that intron 4 of the RHCE gene was ampli®ed. We further characterized the PCR products of 1238 bp and 587 bp obtained from this sample by restriction enzyme analysis and compared them to those obtained from RhD-positive and RhD-negative phenotypes. The restriction fragments obtained from the 1238 bp PCR product of the RHCE gene from the Dc-sample showed the presence of an extra restriction site in the exonic sequence in the same position as that observed in the exonic sequence of the 587 bp fragment of normal RHD gene. This resulted in the absence of the 194 bp fragment and the presence of two fragments of 122 bp and 72 bp instead. We demonstrated the presence of a hybrid RHCE±RHD gene by PCR ampli®cation with allele-speci®c primer. The forward primer was complementary to a sequence speci®c for intron 4 of the RHCE gene. This sequence is located in a region of intron 4 that is deleted in the RHD gene. The reverse primer was speci®c for a sequence of exon 5 of the RHD gene. The product of 807 bp thus obtained may only be explained as coming from an RHCE gene in which exon 5 was substituted by the corresponding exon 5 of the RHD gene. We are performing further analyses to investigate whether other RHD exons are present in this hybrid gene. The molecular characterization of this new phenotype contributes to a better understanding of the enormous polymorphism of the Rhesus blood group system. The presence of a hybrid gene gives origin to a hybrid protein that has clinical implications in transfusion medicine. The characterization of new alleles is useful to guide transfusion therapy properly.
For RhD phenotyping of patients with autoimmune haemolytic anaemia it is necessary to dissociate antibodies from RBCs by elution, without damaging RBC membrane integrity or altering antigen expression. Yet when the af®nity of the antibody is high, the dissociation procedure may be incomplete and lead to wrong results. 2 In one out of 10 patients that we FIGURE 5 . Haemolytic disease of the newborn continues to affect at least one in 1000 births, in spite of prophylactic maternal administration of anti-Rh immunoglobulin. We applied this multiplex PCR method to determine the presence of the RHD gene in foetuses using DNA derived from amniocytes. The results of the RhD type in amniotic-cell DNA agreed totally with the results of the serological typing of cord blood. In all foetal samples studied so far, no discrepancies between serotyping and DNA typing were encountered. Contamination of amniocentesis samples with maternal blood presents a risk for the DNA analysis. In recent years molecular techniques in forensic pathology have been developed for blood and tissue identi®cation that can be used to con®rm or exclude the source of DNA. One of the most commonly used techniques that enables DNA to be pro®led is the analysis of VNTR and STR. 19, 20 In this report we studied the apoB, CSF1PO, TPOX and TH01 loci to con®rm that foetal DNA was used for RHD DNA typing, thus avoiding possible misdiagnosis. In previous studies (unpublished results) we determined the sensitivity at which maternal contamination could be detected with these VNTR and STR loci genotyping by mixing foetal DNA with maternal DNA. We found that 2% maternal DNA mixed with 98% foetal DNA was always detected, and that less than 2% of contamination did not interfere with the detection of the foetal RHD genotype. The prenatal determination of RhD status is of great value in the management of pregnancies in sensitized RhD-negative mothers because no further diagnostic or therapeutic procedures are necessary if the foetus is RhD negative. 11, 18 If testing shows that the foetus is RhD positive, treatment can be planned with suf®cient time.
A major advantage of the technique presented here is that it is rapid and accurate, and can be performed in any laboratory that uses basic molecular biology methodology. The speci®c PCR products can be coampli®ed in a single PCR tube and can be easily differentiated under ultraviolet light after standard agarose gel electrophoresis. For safe and reliable RhD typing we used two independent sets of primers that amplify two different regions of the Rh genes. In this study we investigated a limited number of blood donor samples and a few samples of autoimmune haemolytic anaemia and amniotic¯uid. We were surprised by the fact that we did not ®nd discrepancies between RhD phenotyping and DNA typing in the population studied. Almost all the serological methods used to type blood group antigens on the surface of RBCs depend on direct visualization of erythrocyte agglutination. The major utility of this multiplex PCR approach is to predict patient's RBC RhD phenotype in clinical situations where serological methods are dif®cult or impossible.
